C90.21

Clinical Causes: Exact cause remains unclear, but it involves abnormal growth of plasma cells due to genetic mutations. Potential genetic predispositions that increase risk. Environmental factors such as exposure to radiation or certain chemicals, although definitive links are still under investigation. History of other plasma cell disorders, including multiple myeloma, may increase likelihood. Immune system deficiencies or chronic immune stimulation could play a role.

Key Symptoms: A painless mass or swelling in the affected area, often in the head or neck. Localized discomfort or pressure sensation due to tumor presence. Symptoms related to compression of nearby structures, such as vision issues if near the eyes. In some cases, there may be no noticeable symptoms, especially in early stages.

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests. Imaging studies like MRI, CT scans, or PET scans help locate the tumor. A biopsy is usually performed to confirm the diagnosis by examining tissue samples under a microscope. Blood tests may also be conducted to assess for abnormal plasma cell activity or other related markers. Since extramedullary plasmacytoma can resemble other conditions, a thorough differential diagnosis is essential to rule out multiple myeloma or other malignancies.

Treatment Protocols: Treatment strategies often involve local control of the tumor, including radiation therapy, which is highly effective for extramedullary plasmacytomas. Surgical removal might be considered if feasible, especially for accessible masses. Chemotherapy may be employed in cases where the disease is extensive or recurs. After treatment, patients are generally monitored regularly to detect any signs of recurrence or progression. In remission, ongoing assessments are crucial even when no active disease is evident to ensure early intervention if necessary.